190.611 articles found

Current Perspectives and Practices in Infection-Related Movement Disorders (IRMD): Insights from a Survey of Members of the International Parkinson and Movement Disorder Society.

Garg D, Rosca EC, Iacono D, Ugawa Y, Desai S, Yadav R, Mohamed Ibrahim N, Phokaewvarangkul O, Ojha R, Amod F, Holla VV, Prashanth LK, Schneider SA, Pal PK.

Mov Disord Clin Pract · 2025-09-12

DOI: 10.1002/mdc3.70352PMID: 40940314

Efficient synthesis of l-DOPA in <i>Escherichia coli</i> via cofactor and enzyme engineering.

Deng L, Ping J, Liu Z, Linghu K, Zhang H, Shan X, Zeng W, Li J, Zhou J.

Synth Syst Biotechnol · 2025-09-12

DOI: 10.1016/j.synbio.2025.09.011PMID: 41104292

Rivastigmine for parkinsonian symptoms in dementia with Lewy bodies: a paradigm shift.

Chutia P, Tripathi SM.

Neurodegener Dis Manag · 2025-09-12

DOI: 10.1080/17582024.2025.2558442PMID: 40937755

Bayesian inference captures metabolite-bacteria interactions in a microbial community

Jansma J, Landi P, Hui C.

· 2025-09-11

DOI: 10.1101/2025.09.11.675530

Modulating Cholinergic Hyperactivity Restores Motor Deficits in Parkinson's Disease, Revealed by Quantitative [18F]VAT PET Imaging Vesicular Acetylcholine Transporter

Ye P, Bi L, Qiu Y, Yang M, Liu Y, Hou Y, Zheng P, Wu S, Jin H.

· 2025-09-11

DOI: 10.21203/rs.3.rs-7424059/v1

Alpha-synuclein overexpression reduces neural activity within a basal ganglia vocal nucleus in a zebra finch model

Dominguez BR, Holguin G, Daly MS, Bjork RT, Cowen SL, Miller JE.

· 2025-09-11

DOI: 10.1101/2025.09.11.675693

Epigenetiğin Odontogenez ve Dental Hastalıkların Patogenezindeki Rolü

Tümay, Irmak, Güven, Yeliz

Aydın Dental Journal, Vol. 11 No. 3 · 2025-09-11

Cortical Single-Cell Primers of Abnormal Brain Activity in Parkinson's Disease.

Mirzac D, Glaser MB, Kreis SL, Ringel F, Bange M, Herz DM, Groppa S, Rotaru L, Almeida V, Blech J, Oshaghi M, Kunz S, Klein M, Paulsen J, Luhmann HJ, Bopp T, de Jager PL, Groppa S, Gonzalez-Escamilla G.

Research (Wash D C) · 2025-09-11

DOI: 10.34133/research.0863PMID: 40948939

GLP-1 receptor agonists in Parkinson's disease progression: a meta-analysis with trial sequential analysis of randomized controlled trials.

Tsai WW, Lu KH, Wu JY, Chuang MH, Chen JY, Lai CC, Hung KC, Hsieh MT.

Ther Adv Neurol Disord · 2025-09-11

DOI: 10.1177/17562864251372747PMID: 40951542

Functional characteristics, intercellular interactions and pathophysiological associations of astrocytes in Parkinson's disease.

Li Z, Cao M, Yin Z, Li X, Wang Q, Dong P, Zhou C.

PeerJ · 2025-09-11

DOI: 10.7717/peerj.19998PMID: 40955304

Symptom Networks and Associations with Quality of Life in Patients with Early to Mid-Stage Parkinson's Disease: A Network Analysis.

Deng Q, Duan Y, Yang Z, Wang P, Liu Z, Zhou M.

Degener Neurol Neuromuscul Dis · 2025-09-11

DOI: 10.2147/dnnd.s535306PMID: 40958821

The Cost-Effectiveness of Opicapone Versus Entacapone as Adjuvant Therapy for Levodopa-Treated Individuals With Parkinson's Disease Experiencing End-of-Dose Motor Fluctuations.

Harrison-Jones G, Green W, Bainbridge J.

Parkinsons Dis · 2025-09-11

DOI: 10.1155/padi/8408907PMID: 40979212